In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DJO, ReAble merger hits lawsuit snag:

This article was originally published in Clinica

Executive Summary

A class action lawsuit claiming that DJO shareholders have been left high and dry by the company's proposed merger with ReAble Therapeutics could scupper the $1.6bn bid. The complaint alleges that the deal, which has already received the go-ahead from the US Federal Trade Commission (see Clinica No 1270, p 13), was inadequately priced and breached DJO's fiduciary duty to seek a transaction that would provide shareholders with optimum value. The action calls for an injunction on the merger and monetary damages. DJO said the lawsuit is without merit and will vigorously oppose it. However, the Vista, California company added that it expects further similar lawsuits to be filed.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts